BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahrens R, Waddell A, Seidu L, Blanchard C, Carey R, Forbes E, Lampinen M, Wilson T, Cohen E, Stringer K, Ballard E, Munitz A, Xu H, Lee N, Lee JJ, Rothenberg ME, Denson L, Hogan SP. Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J Immunol. 2008;181:7390-7399. [PMID: 18981162 DOI: 10.4049/jimmunol.181.10.7390] [Cited by in Crossref: 107] [Cited by in F6Publishing: 104] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Munitz A, Seidu L, Cole ET, Ahrens R, Hogan SP, Rothenberg ME. Resistin-like molecule alpha decreases glucose tolerance during intestinal inflammation. J Immunol 2009;182:2357-63. [PMID: 19201890 DOI: 10.4049/jimmunol.0803130] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
2 Vogel ME, Zucker SD. Bilirubin acts as an endogenous regulator of inflammation by disrupting adhesion molecule-mediated leukocyte migration. Inflamm Cell Signal 2016;3:e1178. [PMID: 26925435 DOI: 10.14800/ics.1178] [Cited by in Crossref: 6] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mowat AM, Bain CC. News & Highlights. Mucosal Immunol 2010;3:420-1. [DOI: 10.1038/mi.2010.24] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
4 Coburn LA, Horst SN, Chaturvedi R, Brown CT, Allaman MM, Scull BP, Singh K, Piazuelo MB, Chitnavis MV, Hodges ME, Rosen MJ, Williams CS, Slaughter JC, Beaulieu DB, Schwartz DA, Wilson KT. High-throughput multi-analyte Luminex profiling implicates eotaxin-1 in ulcerative colitis. PLoS One. 2013;8:e82300. [PMID: 24367513 DOI: 10.1371/journal.pone.0082300] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
5 Filippone RT, Sahakian L, Apostolopoulos V, Nurgali K. Eosinophils in Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1140-51. [PMID: 30856253 DOI: 10.1093/ibd/izz024] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
6 Vieira AT, Fagundes CT, Alessandri AL, Castor MG, Guabiraba R, Borges VO, Silveira KD, Vieira EL, Gonçalves JL, Silva TA, Deruaz M, Proudfoot AE, Sousa LP, Teixeira MM. Treatment with a novel chemokine-binding protein or eosinophil lineage-ablation protects mice from experimental colitis. Am J Pathol 2009;175:2382-91. [PMID: 19893035 DOI: 10.2353/ajpath.2009.090093] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 5.1] [Reference Citation Analysis]
7 Polosukhina D, Singh K, Asim M, Barry DP, Allaman MM, Hardbower DM, Piazuelo MB, Washington MK, Gobert AP, Wilson KT, Coburn LA. CCL11 exacerbates colitis and inflammation-associated colon tumorigenesis. Oncogene 2021;40:6540-6. [PMID: 34625710 DOI: 10.1038/s41388-021-02046-3] [Reference Citation Analysis]
8 Waddell A, Ahrens R, Steinbrecher K, Donovan B, Rothenberg ME, Munitz A, Hogan SP. Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C(high) CCR2(+) inflammatory monocyte/macrophage-derived CCL11. J Immunol. 2011;186:5993-6003. [PMID: 21498668 DOI: 10.4049/jimmunol.1003844] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 6.6] [Reference Citation Analysis]
9 Mehta P, Furuta GT. Eosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic Infections. Immunol Allergy Clin North Am 2015;35:413-37. [PMID: 26209893 DOI: 10.1016/j.iac.2015.04.003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 6.4] [Reference Citation Analysis]
10 Wechsler ME, Fulkerson PC, Bochner BS, Gauvreau GM, Gleich GJ, Henkel T, Kolbeck R, Mathur SK, Ortega H, Patel J. Novel targeted therapies for eosinophilic disorders. J Allergy Clin Immunol. 2012;130:563-571. [PMID: 22935585 DOI: 10.1016/j.jaci.2012.07.027] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
11 Bhattacharya S, Kawamura A. Using evasins to target the chemokine network in inflammation. Adv Protein Chem Struct Biol 2020;119:1-38. [PMID: 31997766 DOI: 10.1016/bs.apcsb.2019.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Albert EJ, Duplisea J, Dawicki W, Haidl ID, Marshall JS. Tissue eosinophilia in a mouse model of colitis is highly dependent on TLR2 and independent of mast cells. Am J Pathol 2011;178:150-60. [PMID: 21224053 DOI: 10.1016/j.ajpath.2010.11.041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
13 Masterson JC, McNamee EN, Fillon SA, Hosford L, Harris R, Fernando SD, Jedlicka P, Iwamoto R, Jacobsen E, Protheroe C, Eltzschig HK, Colgan SP, Arita M, Lee JJ, Furuta GT. Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis. Gut 2015;64:1236-47. [PMID: 25209655 DOI: 10.1136/gutjnl-2014-306998] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 9.0] [Reference Citation Analysis]
14 Collins MH. Histopathologic features of eosinophilic esophagitis and eosinophilic gastrointestinal diseases. Gastroenterol Clin North Am. 2014;43:257-268. [PMID: 24813514 DOI: 10.1016/j.gtc.2014.02.007] [Cited by in Crossref: 84] [Cited by in F6Publishing: 67] [Article Influence: 10.5] [Reference Citation Analysis]
15 Nunes NS, Kim S, Sundby M, Chandran P, Burks SR, Paz AH, Frank JA. Temporal clinical, proteomic, histological and cellular immune responses of dextran sulfate sodium-induced acute colitis. World J Gastroenterol 2018; 24(38): 4341-4355 [PMID: 30344419 DOI: 10.3748/wjg.v24.i38.4341] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
16 Hyams JS, Davis S, Mack DR, Boyle B, Griffiths AM, LeLeiko NS, Sauer CG, Keljo DJ, Markowitz J, Baker SS, Rosh J, Baldassano RN, Patel A, Pfefferkorn M, Otley A, Heyman M, Noe J, Oliva-Hemker M, Rufo P, Strople J, Ziring D, Guthery SL, Sudel B, Benkov K, Wali P, Moulton D, Evans J, Kappelman MD, Marquis A, Sylvester FA, Collins MH, Venkateswaran S, Dubinsky M, Tangpricha V, Spada KL, Britt A, Saul B, Gotman N, Wang J, Serrano J, Kugathasan S, Walters T, Denson LA. Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study. Lancet Gastroenterol Hepatol 2017;2:855-68. [PMID: 28939374 DOI: 10.1016/S2468-1253(17)30252-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
17 Munitz A, Cole ET, Beichler A, Groschwitz K, Ahrens R, Steinbrecher K, Willson T, Han X, Denson L, Rothenberg ME. Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis. Gastroenterology. 2010;139:530-541. [PMID: 20398663 DOI: 10.1053/j.gastro.2010.04.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
18 Verma A, Somvanshi P, Haque S, Rathi B, Sharda S. Association of Inflammatory Bowel Disease with Arthritis: Evidence from In Silico Gene Expression Patterns and Network Topological Analysis. Interdiscip Sci Comput Life Sci 2019;11:387-96. [DOI: 10.1007/s12539-017-0272-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Jung Y, Rothenberg ME. Roles and regulation of gastrointestinal eosinophils in immunity and disease. J Immunol. 2014;193:999-1005. [PMID: 25049430 DOI: 10.4049/jimmunol.1400413] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 9.1] [Reference Citation Analysis]
20 Sugawara R, Lee EJ, Jang MS, Jeun EJ, Hong CP, Kim JH, Park A, Yun CH, Hong SW, Kim YM, Seoh JY, Jung Y, Surh CD, Miyasaka M, Yang BG, Jang MH. Small intestinal eosinophils regulate Th17 cells by producing IL-1 receptor antagonist. J Exp Med 2016;213:555-67. [PMID: 26951334 DOI: 10.1084/jem.20141388] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 8.5] [Reference Citation Analysis]
21 Dubois-Camacho K, Diaz-Jimenez D, De la Fuente M, Quera R, Simian D, Martínez M, Landskron G, Olivares-Morales M, Cidlowski JA, Xu X, Gao G, Xie J, Chnaiderman J, Soto-Rifo R, González MJ, Calixto A, Hermoso MA. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis. Front Immunol 2019;10:2449. [PMID: 31824476 DOI: 10.3389/fimmu.2019.02449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
22 Bai L, Scott MKD, Steinberg E, Kalesinskas L, Habtezion A, Shah NH, Khatri P. Computational drug repositioning of atorvastatin for ulcerative colitis. J Am Med Inform Assoc 2021;28:2325-35. [PMID: 34529084 DOI: 10.1093/jamia/ocab165] [Reference Citation Analysis]
23 Karmele EP, Pasricha TS, Ramalingam TR, Thompson RW, Gieseck RL 3rd, Knilans KJ, Hegen M, Farmer M, Jin F, Kleinman A, Hinds DA, Almeida Pereira T, de Queiroz Prado R, Bing N, Tchistiakova L, Kasaian MT, Wynn TA, Vannella KM; 23andMe Research Team. Anti-IL-13Rα2 therapy promotes recovery in a murine model of inflammatory bowel disease. Mucosal Immunol 2019;12:1174-86. [PMID: 31308480 DOI: 10.1038/s41385-019-0189-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
24 Henry EK, Inclan-Rico JM, Siracusa MC. Type 2 cytokine responses: regulating immunity to helminth parasites and allergic inflammation. Curr Pharmacol Rep 2017;3:346-59. [PMID: 29399438 DOI: 10.1007/s40495-017-0114-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
25 Clark PM, Dawany N, Dampier W, Byers SW, Pestell RG, Tozeren A. Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases. Inflamm Bowel Dis. 2012;18:2315-2333. [PMID: 22488912 DOI: 10.1002/ibd.22958] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
26 Lampinen M, Waddell A, Ahrens R, Carlson M, Hogan SP. CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis. J Leukoc Biol. 2013;94:1061-1070. [PMID: 23904440 DOI: 10.1189/jlb.1212640] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
27 Rozenberg P, Reichman H, Zab-Bar I, Itan M, Pasmanik-Chor M, Bouffi C, Qimron U, Bachelet I, Fulkerson PC, Rothenberg ME, Munitz A. CD300f:IL-5 cross-talk inhibits adipose tissue eosinophil homing and subsequent IL-4 production. Sci Rep 2017;7:5922. [PMID: 28725048 DOI: 10.1038/s41598-017-06397-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
28 Alhmoud T, Gremida A, Colom Steele D, Fallahi I, Tuqan W, Nandy N, Ismail M, Aburajab Altamimi B, Xiong MJ, Kerwin A, Martin D. Outcomes of inflammatory bowel disease in patients with eosinophil-predominant colonic inflammation. BMJ Open Gastroenterol 2020;7:e000373. [PMID: 32128230 DOI: 10.1136/bmjgast-2020-000373] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 Rani R, Smulian AG, Greaves DR, Hogan SP, Herbert DR. TGF-β limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function. Eur J Immunol. 2011;41:2000-2009. [PMID: 21469118 DOI: 10.1002/eji.201041135.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014;14:667-685. [PMID: 25234148 DOI: 10.1038/nri3738] [Cited by in Crossref: 647] [Cited by in F6Publishing: 600] [Article Influence: 80.9] [Reference Citation Analysis]
31 Abo H, Flannigan KL, Geem D, Ngo VL, Harusato A, Denning TL. Combined IL-2 Immunocomplex and Anti-IL-5 mAb Treatment Expands Foxp3+ Treg Cells in the Absence of Eosinophilia and Ameliorates Experimental Colitis. Front Immunol 2019;10:459. [PMID: 30930900 DOI: 10.3389/fimmu.2019.00459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Walker MM, Powell N, Talley NJ. Atopy and the gastrointestinal tract--a review of a common association in unexplained gastrointestinal disease. Expert Rev Gastroenterol Hepatol 2014;8:289-99. [PMID: 24450399 DOI: 10.1586/17474124.2014.881716] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
33 Bain CC, Schridde A. Origin, Differentiation, and Function of Intestinal Macrophages. Front Immunol 2018;9:2733. [PMID: 30538701 DOI: 10.3389/fimmu.2018.02733] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 20.3] [Reference Citation Analysis]
34 Shoda T, Collins MH, Rochman M, Wen T, Caldwell JM, Mack LE, Osswald GA, Besse JA, Haberman Y, Aceves SS, Arva NC, Capocelli KE, Chehade M, Davis CM, Dellon ES, Falk GW, Gonsalves N, Gupta SK, Hirano I, Khoury P, Klion A, Menard-Katcher C, Leung J, Mukkada V, Putnam PE, Spergel JM, Wechsler JB, Yang GY, Furuta GT, Denson LA, Rothenberg ME; Consortium of Eosinophilic Gastrointestinal Diseases Researchers (CEGIR). Evaluating Eosinophilic Colitis as a Unique Disease using Colonic Molecular Profiles: A Multi-Site Study. Gastroenterology 2022:S0016-5085(22)00038-5. [PMID: 35085569 DOI: 10.1053/j.gastro.2022.01.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Bischoff SC. Food allergy and eosinophilic gastroenteritis and colitis. Curr Opin Allergy Clin Immunol. 2010;10:238-245. [PMID: 20431371 DOI: 10.1097/aci.0b013e32833982c3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
36 Zucker SD, Vogel ME, Kindel TL, Smith DL, Idelman G, Avissar U, Kakarlapudi G, Masnovi ME. Bilirubin prevents acute DSS-induced colitis by inhibiting leukocyte infiltration and suppressing upregulation of inducible nitric oxide synthase. Am J Physiol Gastrointest Liver Physiol. 2015;309:G841-G854. [PMID: 26381705 DOI: 10.1152/ajpgi.00149.2014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
37 Munitz A, Waddell A, Seidu L, Cole ET, Ahrens R, Hogan SP, Rothenberg ME. Resistin-like molecule alpha enhances myeloid cell activation and promotes colitis. J Allergy Clin Immunol 2008;122:1200-1207.e1. [PMID: 19084112 DOI: 10.1016/j.jaci.2008.10.017] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
38 Kou Y, Xu X, Zhu Z, Dai L, Tan Y. Microbe-set enrichment analysis facilitates functional interpretation of microbiome profiling data. Sci Rep 2020;10:21466. [PMID: 33293650 DOI: 10.1038/s41598-020-78511-y] [Reference Citation Analysis]
39 Wang D, Dubois RN, Richmond A. The role of chemokines in intestinal inflammation and cancer. Curr Opin Pharmacol. 2009;9:688-696. [PMID: 19734090 DOI: 10.1016/j.coph.2009.08.003] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 6.4] [Reference Citation Analysis]
40 van Es T, van Puijvelde GH, Ramos OH, Segers FM, Joosten LA, van den Berg WB, Michon IM, de Vos P, van Berkel TJ, Kuiper J. Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem Biophys Res Commun. 2009;388:261-265. [PMID: 19660432 DOI: 10.1016/j.bbrc.2009.07.152] [Cited by in Crossref: 112] [Cited by in F6Publishing: 108] [Article Influence: 8.6] [Reference Citation Analysis]
41 Ben Baruch-Morgenstern N, Shik D, Moshkovits I, Itan M, Karo-Atar D, Bouffi C, Fulkerson P, Rashkovan D, Jung S, Rothenberg ME, Munitz A. Paired immunoglobulin-like receptor A is an intrinsic, self-limiting suppressor of IL-5-induced eosinophil development. Nat Immunol 2014;15:36-44. [PMID: 24212998 DOI: 10.1038/ni.2757] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
42 Cho YA, Yoon HJ, Hong SD, Lee JI, Hong SP. Hypothetical pathogenesis of eosinophilic infiltration in Langerhans cell histiocytosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116:734-42. [PMID: 23773614 DOI: 10.1016/j.oooo.2013.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
43 Diny NL, Hou X, Barin JG, Chen G, Talor MV, Schaub J, Russell SD, Klingel K, Rose NR, Čiháková D. Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart. Eur J Immunol 2016;46:2749-60. [PMID: 27621211 DOI: 10.1002/eji.201646557] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
44 Jacobs I, Ceulemans M, Wauters L, Breynaert C, Vermeire S, Verstockt B, Vanuytsel T. Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain? Front Immunol 2021;12:754413. [PMID: 34737752 DOI: 10.3389/fimmu.2021.754413] [Reference Citation Analysis]
45 Chen Y, Yang W, Xu C. Expression of Vascular Cell Adhesion Molecule 1 (VCAM-1) in the Mammary Lymph Nodes of Cows with Subclinical Mastitis. J Vet Res 2017;61:203-9. [PMID: 29978074 DOI: 10.1515/jvetres-2017-0026] [Reference Citation Analysis]
46 Adar T, Shteingart S, Ben-ya’acov A, Shitrit AB, Livovsky DM, Shmorak S, Mahamid M, Melamud B, Vernea F, Goldin E. The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications. Dig Dis Sci 2016;61:1915-24. [DOI: 10.1007/s10620-016-4047-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
47 Shah K, Ignacio A, McCoy KD, Harris NL. The emerging roles of eosinophils in mucosal homeostasis. Mucosal Immunol 2020;13:574-83. [PMID: 32157190 DOI: 10.1038/s41385-020-0281-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
48 De Salvo C, Wang XM, Pastorelli L, Mattioli B, Omenetti S, Buela KA, Chowdhry S, Garg RR, Goodman WA, Rodriguez-Palacios A, Smith DE, Abbott DW, Cominelli F, Bamias G, Xin W, Lee JJ, Vecchi M, Pizarro TT. IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis. Am J Pathol 2016;186:885-98. [PMID: 26908008 DOI: 10.1016/j.ajpath.2015.11.028] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
49 Gurtner A, Gonzalez-Perez I, Arnold IC. Intestinal eosinophils, homeostasis and response to bacterial intrusion. Semin Immunopathol 2021;43:295-306. [PMID: 33929602 DOI: 10.1007/s00281-021-00856-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
50 Limketkai BN, Shah SC, Hirano I, Bellaguarda E, Colombel JF. Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis. Gut 2019;68:2152-60. [PMID: 30923072 DOI: 10.1136/gutjnl-2018-318074] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
51 Ferhat M, Hablot J, Taieb M, Salem F, Netter P, Peyrin-Biroulet L, Jouzeau JY, Moulin D. Lack of protective effect of CCR3 blockade during experimental colitis may be related to CCR3 expression by colonic Tregs. Clin Transl Med 2021;11:e455. [PMID: 34185413 DOI: 10.1002/ctm2.455] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Waddell A, Ahrens R, Tsai YT, Sherrill JD, Denson LA, Steinbrecher KA, Hogan SP. Intestinal CCL11 and eosinophilic inflammation is regulated by myeloid cell-specific RelA/p65 in mice. J Immunol 2013;190:4773-85. [PMID: 23562811 DOI: 10.4049/jimmunol.1200057] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
53 Rowley JE, Amargant F, Zhou LT, Galligos A, Simon LE, Pritchard MT, Duncan FE. Low Molecular Weight Hyaluronan Induces an Inflammatory Response in Ovarian Stromal Cells and Impairs Gamete Development In Vitro. Int J Mol Sci 2020;21:E1036. [PMID: 32033185 DOI: 10.3390/ijms21031036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
54 Smyth CM, Akasheh N, Woods S, Kay E, Morgan RK, Thornton MA, O'Grady A, Cummins R, Sheils O, Smyth P, Gleich GJ, Murray FM, Costello RW. Activated eosinophils in association with enteric nerves in inflammatory bowel disease. PLoS One 2013;8:e64216. [PMID: 23717571 DOI: 10.1371/journal.pone.0064216] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
55 Collins MH, Capocelli K, Yang GY. Eosinophilic Gastrointestinal Disorders Pathology. Front Med (Lausanne) 2017;4:261. [PMID: 29379785 DOI: 10.3389/fmed.2017.00261] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
56 Sarangdhar M, Yacyshyn MB, Gruenzel AR, Engevik MA, Harris NL, Aronow BJ, Yacyshyn BR. Therapeutic Opportunities for Intestinal Angioectasia- Targeting PPARγ and Oxidative Stress. Clin Transl Sci 2021;14:518-28. [PMID: 33048460 DOI: 10.1111/cts.12899] [Reference Citation Analysis]
57 Maltby S, Wohlfarth C, Gold M, Zbytnuik L, Hughes MR, McNagny KM. CD34 is required for infiltration of eosinophils into the colon and pathology associated with DSS-induced ulcerative colitis. Am J Pathol. 2010;177:1244-1254. [PMID: 20696776 DOI: 10.2353/ajpath.2010.100191] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
58 Granlund Av, Flatberg A, Østvik AE, Drozdov I, Gustafsson BI, Kidd M, Beisvag V, Torp SH, Waldum HL, Martinsen TC. Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn’s disease and ulcerative colitis. PLoS One. 2013;8:e56818. [PMID: 23468882 DOI: 10.1371/journal.pone.0056818] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 8.4] [Reference Citation Analysis]
59 Franco R, Fernández-Suárez D. Alternatively activated microglia and macrophages in the central nervous system. Prog Neurobiol 2015;131:65-86. [PMID: 26067058 DOI: 10.1016/j.pneurobio.2015.05.003] [Cited by in Crossref: 344] [Cited by in F6Publishing: 341] [Article Influence: 49.1] [Reference Citation Analysis]
60 Griseri T, Arnold IC, Pearson C, Krausgruber T, Schiering C, Franchini F, Schulthess J, McKenzie BS, Crocker PR, Powrie F. Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis. Immunity 2015;43:187-99. [PMID: 26200014 DOI: 10.1016/j.immuni.2015.07.008] [Cited by in Crossref: 101] [Cited by in F6Publishing: 102] [Article Influence: 14.4] [Reference Citation Analysis]
61 Adamkova P, Hradicka P, Kupcova Skalnikova H, Cizkova V, Vodicka P, Farkasova Iannaccone S, Kassayova M, Gancarcikova S, Demeckova V. Dextran Sulphate Sodium Acute Colitis Rat Model: A Suitable Tool for Advancing Our Understanding of Immune and Microbial Mechanisms in the Pathogenesis of Inflammatory Bowel Disease. Veterinary Sciences 2022;9:238. [DOI: 10.3390/vetsci9050238] [Reference Citation Analysis]
62 Loktionov A. Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders. World J Gastroenterol 2019; 25(27): 3503-3526 [PMID: 31367153 DOI: 10.3748/wjg.v25.i27.3503] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 23] [Article Influence: 10.3] [Reference Citation Analysis]
63 Battu S, Afroz S, Giddaluru J, Naz S, Huang W, Khumukcham SS, Khan RA, Bhat SY, Qureshi IA, Manavathi B, Khan AA, August A, Hasnain SE, Khan N. Amino acid starvation sensing dampens IL-1β production by activating riboclustering and autophagy. PLoS Biol 2018;16:e2005317. [PMID: 29621237 DOI: 10.1371/journal.pbio.2005317] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
64 Luhachack LG, Visvikis O, Wollenberg AC, Lacy-Hulbert A, Stuart LM, Irazoqui JE. EGL-9 controls C. elegans host defense specificity through prolyl hydroxylation-dependent and -independent HIF-1 pathways. PLoS Pathog 2012;8:e1002798. [PMID: 22792069 DOI: 10.1371/journal.ppat.1002798] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
65 Kim E, Lembert M, Fallata GM, Rowe JC, Martin TL, Satoskar AR, Reo NV, Paliy O, Cormet-Boyaka E, Boyaka PN. Intestinal Epithelial Cells Regulate Gut Eotaxin Responses and Severity of Allergy. Front Immunol 2018;9:1692. [PMID: 30123215 DOI: 10.3389/fimmu.2018.01692] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
66 Peterson CG, Lampinen M, Hansson T, Lidén M, Hällgren R, Carlson M. Evaluation of biomarkers for ulcerative colitis comparing two sampling methods: fecal markers reflect colorectal inflammation both macroscopically and on a cellular level. Scand J Clin Lab Invest 2016;76:393-401. [PMID: 27223407 DOI: 10.1080/00365513.2016.1185145] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
67 Chang G, Ma N, Zhang H, Wang Y, Huang J, Liu J, Dai H, Shen X. Sodium Butyrate Modulates Mucosal Inflammation Injury Mediated by GPR41/43 in the Cecum of Goats Fed a High Concentration Diet. Front Physiol 2019;10:1130. [PMID: 31543829 DOI: 10.3389/fphys.2019.01130] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
68 Reichman H, Moshkovits I, Itan M, Pasmanik-Chor M, Vogl T, Roth J, Munitz A. Transcriptome profiling of mouse colonic eosinophils reveals a key role for eosinophils in the induction of s100a8 and s100a9 in mucosal healing. Sci Rep 2017;7:7117. [PMID: 28769105 DOI: 10.1038/s41598-017-07738-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
69 Coakley G, Wang H, Harris NL. Intestinal eosinophils: multifaceted roles in tissue homeostasis and disease. Semin Immunopathol 2021;43:307-17. [PMID: 33772336 DOI: 10.1007/s00281-021-00851-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
70 Diny NL, Rose NR, Čiháková D. Eosinophils in Autoimmune Diseases. Front Immunol 2017;8:484. [PMID: 28496445 DOI: 10.3389/fimmu.2017.00484] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 13.4] [Reference Citation Analysis]
71 Zhu X, Liu K, Wang J, Peng H, Pan Q, Wu S, Jiang Y, Liu Y. C‑C chemokine receptor type 3 gene knockout alleviates inflammatory responses in allergic rhinitis model mice by regulating the expression of eosinophil granule proteins and immune factors. Mol Med Rep 2018;18:3780-90. [PMID: 30106146 DOI: 10.3892/mmr.2018.9380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Waddell A, Vallance JE, Fox S, Rosen MJ. IL-33 is produced by colon fibroblasts and differentially regulated in acute and chronic murine colitis. Sci Rep 2021;11:9575. [PMID: 33953267 DOI: 10.1038/s41598-021-89119-1] [Reference Citation Analysis]
73 Travers J, Rothenberg ME. Eosinophils in mucosal immune responses. Mucosal Immunol. 2015;8:464-475. [PMID: 25807184 DOI: 10.1038/mi.2015.2] [Cited by in Crossref: 99] [Cited by in F6Publishing: 91] [Article Influence: 14.1] [Reference Citation Analysis]
74 Moshkovits I, Reichman H, Karo-Atar D, Rozenberg P, Zigmond E, Haberman Y, Ben Baruch-Morgenstern N, Lampinen M, Carlson M, Itan M, Denson LA, Varol C, Munitz A. A key requirement for CD300f in innate immune responses of eosinophils in colitis. Mucosal Immunol 2017;10:172-83. [PMID: 27118491 DOI: 10.1038/mi.2016.37] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
75 Adar T, Shteingart S, Ben Ya'acov A, Bar-Gil Shitrit A, Goldin E. From airway inflammation to inflammatory bowel disease: eotaxin-1, a key regulator of intestinal inflammation. Clin Immunol. 2014;153:199-208. [PMID: 24786916 DOI: 10.1016/j.clim.2014.04.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
76 Lang M, Berry D, Passecker K, Mesteri I, Bhuju S, Ebner F, Sedlyarov V, Evstatiev R, Dammann K, Loy A, Kuzyk O, Kovarik P, Khare V, Beibel M, Roma G, Meisner-Kober N, Gasche C. HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis. Cancer Res. 2017;77:2424-2438. [PMID: 28428272 DOI: 10.1158/0008-5472.can-15-1726] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
77 Wang A, Fernando M, Leung G, Phan V, Smyth D, McKay DM. Exacerbation of oxazolone colitis by infection with the helminth Hymenolepis diminuta: involvement of IL-5 and eosinophils. Am J Pathol. 2010;177:2850-2859. [PMID: 21037078 DOI: 10.2353/ajpath.2010.100537] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
78 Zhou X, Hu H, Balzar S, Trudeau JB, Wenzel SE. MAPK regulation of IL-4/IL-13 receptors contributes to the synergistic increase in CCL11/eotaxin-1 in response to TGF-β1 and IL-13 in human airway fibroblasts. J Immunol 2012;188:6046-54. [PMID: 22573806 DOI: 10.4049/jimmunol.1102760] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
79 Rehman MQ, Beal D, Liang Y, Noronha A, Winter H, Farraye FA, Ganley-Leal L. B cells secrete eotaxin-1 in human inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:922-933. [PMID: 23511032 DOI: 10.1097/mib.0b013e3182802950] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
80 Zhu X, Hogan SP, Molkentin JD, Zimmermann N. Cyclophilin D regulates necrosis, but not apoptosis, of murine eosinophils. Am J Physiol Gastrointest Liver Physiol 2016;310:G609-17. [PMID: 26893161 DOI: 10.1152/ajpgi.00389.2015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
81 Nagy Z, Acs B, Butz H, Feldman K, Marta A, Szabo PM, Baghy K, Pazmany T, Racz K, Liko I, Patocs A. Overexpression of GRß in colonic mucosal cell line partly reflects altered gene expression in colonic mucosa of patients with inflammatory bowel disease. J Steroid Biochem Mol Biol 2016;155:76-84. [PMID: 26480216 DOI: 10.1016/j.jsbmb.2015.10.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
82 Torrente F, Barabino A, Bellini T, Murch SH. Intraepithelial Lymphocyte Eotaxin-2 Expression and Perineural Mast Cell Degranulation Differentiate Allergic/Eosinophilic Colitis From Classic IBD. Journal of Pediatric Gastroenterology & Nutrition 2014;59:300-7. [DOI: 10.1097/mpg.0000000000000432] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
83 Fulkerson PC, Rothenberg ME. Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov 2013;12:117-29. [PMID: 23334207 DOI: 10.1038/nrd3838] [Cited by in Crossref: 249] [Cited by in F6Publishing: 231] [Article Influence: 27.7] [Reference Citation Analysis]
84 Lertnimitphun P, Jiang Y, Kim N, Fu W, Zheng C, Tan H, Zhou H, Zhang X, Pei W, Lu Y, Xu H. Safranal Alleviates Dextran Sulfate Sodium-Induced Colitis and Suppresses Macrophage-Mediated Inflammation. Front Pharmacol 2019;10:1281. [PMID: 31736758 DOI: 10.3389/fphar.2019.01281] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
85 Chusid MJ. Eosinophils: Friends or Foes? The Journal of Allergy and Clinical Immunology: In Practice 2018;6:1439-44. [DOI: 10.1016/j.jaip.2018.04.031] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
86 Moshkovits I, Shik D, Itan M, Karo-atar D, Bernshtein B, Hershko AY, van Lookeren Campagne M, Munitz A. CMRF35-like molecule 1 (CLM-1) regulates eosinophil homeostasis by suppressing cellular chemotaxis. Mucosal Immunol 2014;7:292-303. [DOI: 10.1038/mi.2013.47] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
87 Johnsson M, Bove M, Bergquist H, Olsson M, Fornwall S, Hassel K, Wold AE, Wennerås C. Distinctive blood eosinophilic phenotypes and cytokine patterns in eosinophilic esophagitis, inflammatory bowel disease and airway allergy. J Innate Immun 2011;3:594-604. [PMID: 21921589 DOI: 10.1159/000331326] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
88 Filippone RT, Robinson AM, Jovanovska V, Stavely R, Apostolopoulos V, Bornstein JC, Nurgali K. Targeting eotaxin-1 and CCR3 receptor alleviates enteric neuropathy and colonic dysfunction in TNBS-induced colitis in guinea pigs. Neurogastroenterol Motil 2018;30:e13391. [DOI: 10.1111/nmo.13391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
89 Sekiya M, Kiyohara H, Maruyama H, Yabe T, Yamada H. Modulation of chemokine expression on intestinal epithelial cells by Kampo (traditional Japanese herbal) medicine, Hochuekkito, and its active ingredients. J Nat Med 2013;67:626-35. [DOI: 10.1007/s11418-012-0724-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
90 Chojnacki A, Wojcik K, Petri B, Aulakh G, Jacobsen EA, LeSuer WE, Colarusso P, Patel KD. Intravital imaging allows real-time characterization of tissue resident eosinophils. Commun Biol 2019;2:181. [PMID: 31098414 DOI: 10.1038/s42003-019-0425-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
91 Richer E, Yuki KE, Dauphinee SM, Larivière L, Paquet M, Malo D. Impact of Usp18 and IFN signaling in Salmonella-induced typhlitis. Genes Immun 2011;12:531-43. [DOI: 10.1038/gene.2011.38] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
92 Svensson-Frej M. Immunobiology of intestinal eosinophils - a dogma in the changing? J Innate Immun. 2011;3:565-576. [PMID: 21860213 DOI: 10.1159/000328799] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
93 Huang Y, Dalal S, Antonopoulos D, Hubert N, Raffals LH, Dolan K, Weber C, Messer JS, Jabri B, Bendelac A, Eren AM, Rubin DT, Sogin M, Chang EB. Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis. Inflamm Bowel Dis 2017;23:366-78. [PMID: 28221248 DOI: 10.1097/MIB.0000000000001027] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
94 Marichal T, Mesnil C, Bureau F. Homeostatic Eosinophils: Characteristics and Functions. Front Med (Lausanne) 2017;4:101. [PMID: 28744457 DOI: 10.3389/fmed.2017.00101] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 13.0] [Reference Citation Analysis]
95 Caprara G, Allavena P, Erreni M. Intestinal Macrophages at the Crossroad between Diet, Inflammation, and Cancer. Int J Mol Sci 2020;21:E4825. [PMID: 32650452 DOI: 10.3390/ijms21144825] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
96 Haasnoot ML, Mookhoek A, Duijvestein M, D'Haens GRAM, Bredenoord AJ. Prognostic Value of Colonic Tissue and Blood Eosinophils in Ulcerative Colitis. Inflamm Bowel Dis 2022:izac044. [PMID: 35275200 DOI: 10.1093/ibd/izac044] [Reference Citation Analysis]
97 Vieira EL, Leonel AJ, Sad AP, Beltrão NR, Costa TF, Ferreira TM, Gomes-santos AC, Faria AM, Peluzio MC, Cara DC, Alvarez-leite JI. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. The Journal of Nutritional Biochemistry 2012;23:430-6. [DOI: 10.1016/j.jnutbio.2011.01.007] [Cited by in Crossref: 158] [Cited by in F6Publishing: 157] [Article Influence: 15.8] [Reference Citation Analysis]
98 Rani R, Smulian AG, Greaves DR, Hogan SP, Herbert DR. TGF-β limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function. Eur J Immunol 2011;41:2000-9. [PMID: 21469118 DOI: 10.1002/eji.201041135] [Cited by in Crossref: 56] [Cited by in F6Publishing: 62] [Article Influence: 5.1] [Reference Citation Analysis]
99 Radnai B, Sturm EM, Stančić A, Jandl K, Labocha S, Ferreirós N, Grill M, Hasenoehrl C, Gorkiewicz G, Marsche G, Heinemann Á, Högenauer C, Schicho R. Eosinophils Contribute to Intestinal Inflammation via Chemoattractant Receptor-homologous Molecule Expressed on Th2 Cells, CRTH2, in Experimental Crohn's Disease. J Crohns Colitis 2016;10:1087-95. [PMID: 26928963 DOI: 10.1093/ecco-jcc/jjw061] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
100 Villarroya F, Cereijo R, Villarroya J, Gavaldà-navarro A, Giralt M. Toward an Understanding of How Immune Cells Control Brown and Beige Adipobiology. Cell Metabolism 2018;27:954-61. [DOI: 10.1016/j.cmet.2018.04.006] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 20.8] [Reference Citation Analysis]
101 Click B, Anderson AM, Koutroubakis IE, Rivers CR, Babichenko D, Machicado JD, Hartman DJ, Hashash JG, Dunn MA, Schwartz M, Swoger J, Barrie A III, Wenzel SE, Regueiro M, Binion DG. Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype. Am J Gastroenterol 2017;112:1849-58. [PMID: 29112200 DOI: 10.1038/ajg.2017.402] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
102 Woodruff SA, Masterson JC, Fillon S, Robinson ZD, Furuta GT. Role of eosinophils in inflammatory bowel and gastrointestinal diseases. J Pediatr Gastroenterol Nutr. 2011;52:650-661. [PMID: 21593640 DOI: 10.1097/mpg.0b013e3182128512] [Cited by in Crossref: 50] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
103 Biedermann L, Straumann A, Greuter T, Schreiner P. Eosinophilic esophagitis-established facts and new horizons. Semin Immunopathol 2021;43:319-35. [PMID: 34097125 DOI: 10.1007/s00281-021-00855-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Boyle B, Collins MH, Wang Z, Mack D, Griffiths A, Sauer C, Markowitz J, LeLeiko N, Keljo D, Rosh J, Baker SS, Pfefferkorn M, Heyman M, Patel A, Baldassano R, Noe J, Rufo P, Kugathasan S, Walters T, Denson L, Hyams J; PROTECT Study Group. Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative Colitis. Am J Surg Pathol 2017;41:1491-8. [PMID: 28863076 DOI: 10.1097/PAS.0000000000000939] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 4.2] [Reference Citation Analysis]
105 Sturm EM, Radnai B, Jandl K, Stančić A, Parzmair GP, Högenauer C, Kump P, Wenzl H, Petritsch W, Pieber TR, Schuligoi R, Marsche G, Ferreirós N, Heinemann A, Schicho R. Opposing roles of prostaglandin D2 receptors in ulcerative colitis. J Immunol 2014;193:827-39. [PMID: 24929001 DOI: 10.4049/jimmunol.1303484] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
106 Vande Casteele N, Leighton JA, Pasha SF, Cusimano F, Mookhoek A, Hagen CE, Rosty C, Pai RK, Pai RK. Utilizing Deep Learning to Analyze Whole Slide Images of Colonic Biopsies for Associations Between Eosinophil Density and Clinicopathologic Features in Active Ulcerative Colitis. Inflamm Bowel Dis 2021:izab122. [PMID: 34106256 DOI: 10.1093/ibd/izab122] [Reference Citation Analysis]
107 Masterson JC, McNamee EN, Jedlicka P, Fillon S, Ruybal J, Hosford L, Rivera-Nieves J, Lee JJ, Furuta GT. CCR3 Blockade Attenuates Eosinophilic Ileitis and Associated Remodeling. Am J Pathol 2011;179:2302-14. [PMID: 21945903 DOI: 10.1016/j.ajpath.2011.07.039] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]